1LyMwl4

CONSENSO DE VALVULOPATÍAS 91
Carpentier-Edwards PERIMOUNT Investigators. Ann Thorac Surg
2001;71(5 Suppl):S285-288.
22. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski
H. Late hemodynamic and clinical outcomes of aortic valve
replacement with the Carpentier-Edwards Perimount pericardial
bioprosthesis. J Thorac Cardiovasc Surg 2002;124:146-54.
23. Fan JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB.
Twenty-year clinical experience with porcine bioprosthesis. Ann
Thorac Surg 1996;62:1301-11.
24. Valfre C, Rizzoli G, Zussa C, Ius P, Polesel E, Mirone S, et al.
Clinical results of Hancock II versus Hancock Standard at long-term
follow-up. J Thorac Cardiovasc Surg 2006;132:595-601.
25. Riess FC, Bader R, Cramer E, Hansen L, Kleijnen B, Wahl G,
et al. Hemodynamic performance of the Medtronic Mosaic Porcine
bioprosthesis up to ten years. Ann Thorac Surg 2007;83:1310-8.
26. Myken PS. Seventeen-year experience with the St. Jude Medical
Biocor porcine prosthesis. J Heart Valve Dis 2005;14:486-92.
27. Jamieson WR, Bur LH, Munto I, Miyagishima RT. Carpentier-
Edwards standard porcine bioprosthesis a 21-year experience. Ann
Thorac Surg 1998;66:S40-3.
28. Bavaria JE, Desai ND, Cheung A, Petracek MR, Groh MA, Borger
MA, et al. The St. Jude Medical Trifecta aortic pericardial valve: Results
from a global, multicenter, prospective clinical study. J Thorac
Cardiovasc Surg 2014;147:590-7.
29. Kerchove L, Glineur D, El Khoury G, Noirhomme P. Stentless
valves for aortic valve replacement: where do we stand? Curr Opin
Cardiol 2007;22:96-103.
30. Dagenais F, Cartier P, Voisine P, Desaulniers D, Perron J, Baillot
R, et al. Which biologic valve should we select for the 45-to-65 yearold
group requiring aortic valve replacement? J Thorac Cardiovasc
Surg 2005;129:1041-9.
31. Yap CH, Yii M. Allograft aortic valve replacement in the adult: A
review. Heart Lung Circ 2004;13:41-51.
32. O’Brien MF, Harrocks S, Stafford EG, Gardner MA, Pohlner PG,
Tesar PJ, et al. The homograft aortic valve: a 29-year, 99.3% followup
of 1022 valve replacements. J Heart Valve Dis 2001;10:334-45.
33. Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM.
Are allografts the biologic valve of choice for aortic valve replacement
in nonelderly patients? Comparison of explantation for structural
valve deterioration of allografts and pericardial prosthesis. J Thorac
Cardiovasc Surg 2006;131:558-64.
34. El-Hamamsy I, Clark L, Stevens LM, Sarang Z, Melina G, Takkenberg
JJ, et al. Late outcomes following freestyle versus homograft
aortic root replacement: results from a prospective randomized trial.
J Am Coll Cardiol 2010;55:368-76.
35. Takkenberg JJM, Klieverik LMA, Bekkers JA, Kappetein AP, Roos
JW, Eijkemans MJ, et al. Allografts for aortic valve or root replacement:
insights from a 18-year single-center prospective follow-up
study. Eur J Cardiothorac Surg 2007;31:851-9.
36. Yankah AC, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R.
Homograft reconstruction of the aortic root for endocarditis with
periannular abscess: a 17-year study. Eur J Cardiothorac Surg
2005;28:69-75.
37. Grinda JM, Mainardi JL, D’Attellis N, Bricourt MO, Berrebi A,
Fabiani JN, et al. Cryopreserved aortic viable homograft for active
aortic endocarditis. Ann Thorac Surg 2005;79:767-71.
38. Favaloro RR, Casabé H, Stutzbach P y cols. Homoinjertos y autoinjertos
en la endocarditis infecciosa aórtica en actividad: resultados
inmediatos y a mediano plazo. Rev Argent Cardiol 2000;68:555-61.
39. Ross DN. Replacement of aortic and mitral valves with a pulmonary
autograft. Lancet 1967;2:256-9.
40. Favaloro R, Stutzbach P, Caramutti V, Machain A y cols. Enfermedad
de la válvula aórtica: resultados a 3 años de la cirugía de Ross.
Rev Argent Cardiol 1999;67:317-24.
41. Favaloro RR, Roura P, Gomez C, Salvatori C. Aortic valve replacement:
ten-year follow up of the Ross procedure. J Heart Valve Dis
2008;17:501-7.
42. Yacoub MH, Klieverik LMA, Melina G, Edwards SE, Sarathchandra
P, Bogers AJ, et al. An evaluation of the Ross operation
in adults. J Heart Valve Dis 2006;15:531-9.
43. Chiappini B, Absil B, Rubay J, Noirhomme P, Funken JC, Verhelst
R, et al. The Ross procedure: Clinical and echocardiographic followup
in 219 consecutive patients. Ann Thorac Surg 2007;83:1285-9.
44. JH, Hiro SP, Maxwell JM, Lamberti JJ, Duran CM. The
Ross procedure: Current registry results. Ann Thorac Surg
1998;66(Suppl):S162-5.
45. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark
L, et al. Long-term outcomes after autograft versus homograft aortic
root replacement in adults with aortic valve disease: a randomised
controlled trial. Lancet 2010;376:524-31.
46. Takkenberg JJM, Klieverik LMA, Schoof PH, Van Suylen RJ, Van
Herwerden LA, Zondervan PE, et al. The Ross procedure: a systematic
review and meta-analysis. Circulation 2009;119:222-8.
47. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield
JE, Galie N, et al. Task Force on the Management of Grown-up Congenital
Heart Disease of the European Society of Cardiology (ESC).
ESC Guidelines for the management of grown-up congenital heart
disease. Eur Heart J 2010;31:2915-57.
48. Mokhels MM, Rizopoulos D, Andrinopoulou ER, Bekkers JA,
Roos-Hesselink JW, Lesaffre E, et al. Autograft and pulmonary allograft
performance in the second post-operative decade after the
Ross procedure: insights from the Rotterdam Prospective Cohort
Study. Eur Heart J 2012;33:2213-24.
49. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and
relative survival after aortic valve replacement. J Am Coll Cardiol
2000;35:747-56.
50. Takkenberg JJM, Puvimanasinghe JP, Grunkemeier GL. Simulation
models to predict outcome after aortic valve replacement. Ann
Thorac Surg 2003;75:1372-6.
51. Klieverik LMA, Noorlander M, Takkenberg JJM, Kappetein AP,
Bekkers JA, van Herwerden LA, et al. Outcome after aortic valve
replacement in young adults: is patient profile more important than
prosthesis type? J Heart Valve Dis 2006;15:479-87.
52. Rozich JD, Carabello BA, Usher BW, Kappetein AP, Bekkers JA,
van Herwerden LA, et al. Mitral valve replacement with and without
chordal preservation in patients with chronic mitral regurgitation:
mechanisms for differences in post-operative ejection performance.
Circulation 1992;86:1718-26.
53. Otto CM. Surgical intervention for mitral regurgitation. En: Otto
CM, editor. Valvular Heart Disease. 2 nd ed. Saunders; 2004. p. 388.
54. Bonow R, Carabello B, Chatterjee K, de Leon AC Jr, Faxon DP,
Freed MD, et al. 2008 Focused Update Incorporated into the ACC/AHA
Practical Guidelines for the Management of patients with valvular
heart disease: Executive summary. A Report of the American College
of Cardiology/American Heart Association Task Force and Practice
Guidelines. J Am Coll Cardiol 2008;52:e1-e142.
55. Vahanian A, Alfier O, Andreotti F, Antunes MJ, Barón-Esquivias
G, Baumgartner H, et al. Guidelines on the management of valvular
heart disease (version 2012). The Joint Task Force on the Management
of Valvular Heart Disease of the European Society of Cardiology
(ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS). Eur J Cardiothorac Surg 2012;42:S1-44.
56. Buzzatti N, Iaci G, Taramasso M, Nisi T, Lapenna E, De Bonis M,
et al. Long-term outcomes of tricuspid valve replacement after previous
left-side heart surgery. Eur J Cardiothorac Surg 2014;46:713-9.
57. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year
comparison of a Bjork-Shiley mechanical heart valve with porcine
bioprostheses. N Engl J Med 1991;324:573-9.
58. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim
T, Rahimtoola S. A comparison of outcomes in men 11 years after
heart-valve replacement with a mechanical valve or bioprosthesis.
Veterans Affairs Cooperative Study on Valvular Heart Disease. N
Engl J Med 1993;328:1289-96.
59. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith
R, et al. Fourteen-year experience with homovital homografts for aortic
valve replacement. J Thorac Cardiovasc Surg 1995;110:186-93.